Search

Your search keyword '"Huizing, M."' showing total 562 results

Search Constraints

Start Over You searched for: Author "Huizing, M." Remove constraint Author: "Huizing, M."
562 results on '"Huizing, M."'

Search Results

1. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment

2. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

3. Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study

5. Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

8. Clinical Pharmacology of Carboplatin Administered in Alternating Sequence with Paclitaxel in Patients with Non-Small Cell Lung Cancer: A European Cancer Centre (ECC) Study

10. 36P Alterations in tumour-promoting cytokines in cancer patients after SARS-CoV-2 infection

11. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

33. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

35. Vaccination of cancer patients with dendritic cells electroporated with mRNA encoding the wilms' tumor 1 protein (WT1): correlation of clinical effect and overall survival with T-cell response

36. Biobanking for Viral Hepatitis Research

37. Biobanking for Viral Hepatitis Research

39. Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial

40. Program and abstracts for the 2011 Meeting of the Society for Glycobiology

41. Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: Analysis of the AURELIA trial

43. A review regarding the feasibility and accuracy of a sentinel lymph node biopsy after neo-adjuvant chemotherapy for breast cancer.

44. Evidence that rab27a mutations are associated with neurological involvement, not simply the hemophagocytic syndrome, in patients with Griscelli syndrome

45. Mutations in a novel gene, SUTAL, cause a unique form of Hermansky-Pudlak syndrome, HPS-3

47. The CTNS promter and its mutations causing cystinosis

Catalog

Books, media, physical & digital resources